SOCIETE DE THERAPEUTIQUE MAROCAINE S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 985 MAD | -2.38% |
|
-2.48% | +3.58% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2023 | - | Sales 2024 * | - | Capitalization | 7.09B 71.18B |
|---|---|---|---|---|---|
| Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 | - |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
| P/E ratio 2023 |
26.1
x | P/E ratio 2024 * |
21.4
x | Employees | - |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 10.68% |
More Fundamentals
* Assessed data
More news
More news
| 1 day | -0.10% | ||
| 1 week | +2.75% | ||
| Current month | +2.94% | ||
| 1 month | +6.10% | ||
| 3 months | +1.92% | ||
| 6 months | -1.08% | ||
| Current year | +6.10% |
1 week
985.00
1 010.00
1 month
951.001 050.00
Current year
923.001 065.00
1 year
923.001 260.00
3 years
900.001 750.00
5 years
375.001 750.00
10 years
278.751 750.00
| Managers | Title | Age | Since |
|---|---|---|---|
Lamia Tazi
CEO | Chief Executive Officer | 47 | 97-10-05 |
Adnane Hilal
DFI | Director of Finance/CFO | - | - |
Mehdi Zaghloul
COO | Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mohamed Tazi
BRD | Director/Board Member | - | - |
Bahia Berrada
BRD | Director/Board Member | - | - |
Karim Berrada
BRD | Director/Board Member | - | 06-06-28 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 985 | -2.38% | 13 |
| 24-05-09 | 1,009 | -0.10% | 130 |
| 24-05-08 | 1,010 | +2.54% | 5 |
| 24-05-06 | 985 | -2.48% | 5 |
End-of-day quote Casablanca S.E., May 08, 2024
More quotes
Sothema (Société de Thérapeutique Marocaine) is No. 1 in Morocco of manufacturing and marketing licensed pharmaceutical products and biotechnology drugs. The group's activity is organized around 3 areas:
- drug sales: products made under license and under own names;
- importing and sales of drugs, dental products, and ophthalmic equipment;
- subcontractor fabrication of pharmaceutical products: services provided to Moroccan and foreign laboratories.
At the end of 2019, Sothema had 6 production units located in Morocco.
Sector
Pharmaceuticals
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
985
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +6.10% | 706M | |
| +30.38% | 684B | |
| +29.71% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.26% | 240B | |
| +8.93% | 208B | |
| -7.61% | 200B | |
| +7.68% | 166B |
- Stock Market
- Equities
- SOT Stock
